Provider
Provider
Dr. Schiopu is the Director of Clinical Trials for the Division of Rheumatology. She graduated from “Gr.T. Popa” University of Medicine and Pharmacy in Romania and did her medical training at Robert Wood Johnson medical school in New Jersey to Wayne State University in Detroit, after which she became faculty at University of Michigan in the Scleroderma Program, Director of the Myositis Program and the Rheumatology Lead for the combined Oncology-Rheumatology Initiative in immune checkpoint inhibitors. Her clinical research includes the first randomized controlled trial in myositis (RIM trial) and developing outcome measures in Scleroderma (CRISS) and Myositis (TIS), StopRA, photoacoustic imaging in Rheumatic structures. She currently serves in the scientific committee of the International Myositis Assessment & Clinical Studies Group (IMACS), and was a member of the University of Michigan IRB, the University of Michigan Senate Advisory Committee on University Affairs (SACUA) on the President’s and Provost’s COVID-19 Faculty Council in 2020, and the first rheumatologist to mentor a team from the University of Michigan Department of Biomedical Engineering (BME) Graduate Innovative Design in Biomedical Engineering course for the 2019-2020 academic year. She is a passionate educator and among others, she was honored by the University of Michigan Learning Environment Task Force (LETF) for her exemplary work in cultivating and upholding a positive learning environment for U-M Medical School students (2017), and received the Dean award in 2019 as an MD PhD candidate switched his residency application from Ob-Gyn to Medicine after working with her. She is an advisory member of the Scleroderma Foundation, The Myositis Association and Sjogren’s Foundation and feels privileged to be part of the greater Augusta medical community.
RA, PsA, AS, Scleroderma, Myositis, Sjogren's Syndrome
Outcome measures in idiopathic inflammatory myopathies, therapeutics in connective tissue conditions and fibrotic conditions
communication, mutual respect, freedom of speech, clinical excellence
Resources & Tools.
Here are a few helpful resources to guide your next steps
Select your preferences below, so we can deliver the most relevant content to you:
Select your preferences below, so we can deliver the most relevant content to you: